Alaunos Therapeutics (TCRT) Share-based Compensation (2016 - 2025)
Historic Share-based Compensation for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $301000.0.
- Alaunos Therapeutics' Share-based Compensation rose 27625.0% to $301000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $634000.0, marking a year-over-year increase of 514.1%. This contributed to the annual value of $435000.0 for FY2024, which is 8446.43% down from last year.
- Per Alaunos Therapeutics' latest filing, its Share-based Compensation stood at $301000.0 for Q3 2025, which was up 27625.0% from $184000.0 recorded in Q2 2025.
- Over the past 5 years, Alaunos Therapeutics' Share-based Compensation peaked at $5.3 million during Q2 2021, and registered a low of $68000.0 during Q1 2025.
- Its 5-year average for Share-based Compensation is $952105.3, with a median of $808000.0 in 2022.
- Per our database at Business Quant, Alaunos Therapeutics' Share-based Compensation tumbled by 8898.07% in 2024 and then skyrocketed by 27625.0% in 2025.
- Quarter analysis of 5 years shows Alaunos Therapeutics' Share-based Compensation stood at $917000.0 in 2021, then fell by 4.36% to $877000.0 in 2022, then plummeted by 71.49% to $250000.0 in 2023, then tumbled by 67.6% to $81000.0 in 2024, then soared by 271.6% to $301000.0 in 2025.
- Its Share-based Compensation was $301000.0 in Q3 2025, compared to $184000.0 in Q2 2025 and $68000.0 in Q1 2025.